Related Experiment Video
Updated: Jun 2, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer
Lora Stojanovic1,2, Rachel Abbotts1,2, Kaushelendra Tripathi1,2
1University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland.
Abstract:
DNA methyltransferase (DNMT) and PARP inhibitors induce a stimulator of IFN gene-dependent pathogen mimicry response (PMR) in ovarian and other cancers. In this study, we showed that combining DNMT and PARP inhibitors upregulates expression of the nucleic acid sensor NFX1-type zinc finger-containing 1 (ZNFX1) protein. ZNFX1 mediated the induction of PMR in mitochondria, serving as a gateway for stimulator of IFN gene-dependent IFN/inflammasome signaling. Loss of ZNFX1 in ovarian cancer cells promoted proliferation and spheroid formation in vitro and tumor growth in vivo. In patient ovarian cancer databases, expression of ZNFX1 was elevated in advanced stage disease, and ZNFX1 expression alone significantly correlated with an increase in overall survival in a phase III trial for patients with therapy-resistant ovarian cancer receiving bevacizumab in combination with chemotherapy. RNA sequencing revealed an association between inflammasome signaling through ZNFX1 and abnormal vasculogenesis. Together, this study identified that ZNFX1 is a tumor suppressor that controls PMR signaling through mitochondria and may serve as a biomarker to facilitate personalized therapy in patients with ovarian cancer. Significance: DNMT and PARP inhibitors induce a nucleic acid sensor, ZNFX1, that serves as a mitochondrial gateway to STING-dependent inflammasome signaling with tumor suppressor properties in ovarian cancer.
Insights
DNA methyltransferase (DNMT) and PARP inhibitors upregulate ZNFX1, a protein that triggers a pathogen mimicry response (PMR). ZNFX1 acts as a tumor suppressor in ovarian cancer, potentially serving as a biomarker for personalized therapy.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- DNA methyltransferase (DNMT) and PARP inhibitors can induce a pathogen mimicry response (PMR) in various cancers.
- This response is dependent on the stimulator of IFN genes (STING).
Purpose of the Study:
- To investigate the role of ZNFX1 in mediating the PMR induced by DNMT and PARP inhibitors.
- To explore ZNFX1's function as a tumor suppressor in ovarian cancer and its potential as a therapeutic biomarker.
Main Methods:
- Combining DNMT and PARP inhibitors in cancer cells.
- Assessing ZNFX1 protein expression and its role in signaling pathways.
- In vitro and in vivo functional assays to evaluate ZNFX1's impact on cancer cell proliferation and tumor growth.
- Analysis of patient ovarian cancer databases and clinical trial data.
Main Results:
- Combined DNMT and PARP inhibition upregulated ZNFX1 expression.
- ZNFX1 mediated PMR through mitochondria, acting as a gateway for STING-dependent IFN/inflammasome signaling.
- Loss of ZNFX1 promoted ovarian cancer cell proliferation, spheroid formation, and tumor growth.
- Elevated ZNFX1 expression correlated with advanced disease but also with increased survival in therapy-resistant ovarian cancer patients.
- ZNFX1 signaling was associated with abnormal vasculogenesis.
Conclusions:
- ZNFX1 is a tumor suppressor that regulates mitochondrial PMR signaling.
- ZNFX1 acts as a crucial mediator in the STING-dependent inflammasome pathway.
- ZNFX1 may serve as a valuable biomarker for personalized therapeutic strategies in ovarian cancer.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
10:57NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Epigenetic Regulation
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...